• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

UnitedHealthcare Removes Out-of-Pocket Costs for Eligible Members Using 24/7 Virtual Visits

Article

Removing out-of-pocket expenses for the accessible virtual visits may help improve health equity by reducing medical costs for consumers and encourage earlier interventions. In turn, interventions may reduce the risk of complications and avoid visits to more expensive settings like the emergency room.

Eligible members of UnitedHealthcare will no longer have out-of-pocket costs for 24/7 Virtual Visits if they are enrolled in applicable fully insured employer-sponsored plans. These members can access healthcare professionals any time to treat a variety of medical issues.

Those eligible for these plans will have access to this coverage enhancement upon renewal and for new plans.

Dr. Donna O’Shea, chief medical officer of population health for UnitedHealthcare, said the coverage update will be offered to some fully insured plans, beginning with larger employers, starting July 1.

UnitedHealthcare will continue to add more employers throughout this year and next year, eventually extending the waiver to more than 5 million fully insured members by the end of 2024, O’Shea said.

“We are also working with employers with self-funded plans to make this coverage option available to their employees,” she added.

Removing out-of-pocket expenses for the accessible virtual visits may help improve health equity by reducing medical costs for consumers and encourage earlier interventions, according to a release by UnitedHealthcare. In turn, interventions can reduce the risk of complications and avoid visits to more expensive settings like the emergency room.

As an effort to use health technology to access quality care and an affordable price, the 24/7 Virtual Visits service is an alternative option to services delivered by local care providers. The visits make up approximately 95% of virtual care appointments among UnitedHealthcare members, the release said.
Members can benefit from this service by connecting on demand to a care provider by video or phone through myuhc.com or the UnitedHealthcare app. The service includes national care providers like Optum Virtual Care.

24/7 Virtual Visits may treat many of the same conditions — like flu or pinkeye — as an ER or urgent care. Patients are treated to a more convenient and affordable alternative — particularly at night or on weekends when most primary care providers are usually unavailable.

Related Videos
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Video 5 - "Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics"
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Video 1 - "Overview of Prescription Digital Therapeutics and Impact on Clinical Practice"
Video 4 - "Payer Challenges in Evaluating Digital Therapeutics"
Related Content
© 2024 MJH Life Sciences

All rights reserved.